Improvement of European translational cancer research. Collaboration between comprehensive cancer centers.
Even though the increasing incidence of cancer is mainly a consequence of a population with a longer life span, part of this augmentation is related to the increasing prevalence of patients living with a chronic cancer disease. To fight the problem, improved preventive strategies are mandatory in combination with an innovative health care provision that is driven by research. To overcome the weakness of translational research the OECI is proposing a practical approach as part of a strategy foreseen by the EUROCAN+PLUS feasibility study, which was launched by the EC in order to identify mechanisms for the coordination of cancer research in Europe.
Ringborg
Ulrik
U
Cancer Center Karolinska, Karolinska University Hospital, Sweden. ulrik.ringborg@karolinska.se
de Valeriola
Dominique
D
van Harten
Wim
W
Bosch
Antonio Llombart
AL
Lombardo
Claudio
C
Nilsson
Kenneth
K
Philip
Thierry
T
Pierotti
Marco A
MA
Riegman
Peter
P
Saghatchian
Mahasti
M
Storme
Guy
G
Tursz
Thomas
T
Verellen
Dirk
D
D035843:Biomedical Research; D002173:Cancer Care Facilities / Q000639:trends; D002908:Chronic Disease; D003299:Cooperative Behavior; D005062:European Union; D006801:Humans; D009369:Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D009939:Organizations, Nonprofit; D015995:Prevalence